Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miranza is a leading network of ophthalmology centers in Spain and Andorra, specializing in high-complexity eye care and surgical procedures. Established in 2019 through the consolidation of several prestigious clinics, the group operates over 30 facilities and employs a large team of specialized ophthalmologists. The company focuses on clinical excellence, utilizing advanced diagnostic and surgical technologies to treat a wide range of ocular conditions, including cataracts, glaucoma, and retinal disorders. Miranza also maintains a dedicated research division that participates in international clinical trials to advance ophthalmic science. In 2022, the group was acquired by veonet, a pan-European ophthalmology network, expanding its reach and resources within the European healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miranza.